Ceva Animal Health has launched Assure Ewe, a subsidised testing scheme to assist practitioners identify the cause of enzootic abortion on-farm.

The company says industry estimates are that 12 million accessible breeding ewes (91%) are not vaccinated against enzootic abortion in the UK, and that this should concern all practitioners with sheep clients.

Any flock with an abortion rate of over 2% could, it says, be suffering from the disease, and at a cost of £85 per aborted ewe, those are losses producers can ill-afford to ignore.

Stephenie Clarke from Ceva said: "Abortion remains one of the most significant reasons for loss in sheep flocks and an abortion storm can lead to crippling results on farm.

"Enzootic abortion caused by C. abortus remains the main cause of ovine abortion in the UK¹ and once in a flock, takes time to control as exposed ewes can become latently infected."

Assure Ewe is a subsidised blood testing scheme open to all flocks with 50 or more breeding ewes. In contrast to other schemes, evidence of an abortion does not need to have taken place.

Blood samples should be collected from six ewes, with full farm and vet details also supplied. Upon results, Ceva says it will share information with the participating veterinary surgeon to discuss with the farmer.

Stephenie added: "Assure Ewe is a very user-friendly, simple scheme that will help facilitate conversations between vets and farmers while, at the same time, providing useful testing information to vets. Ceva encourages evidence based veterinary decisions, and this is just one example of such an initiative."

If C. abortus is identified in a flock, a veterinary-devised plan combining vaccination with Cevac Chlamydia, biosecurity and only purchasing stock from accredited flocks will assist disease control and eventual eradication.

For further information about the scheme, contact your Ceva territory manager.

Reference

1. Nadis Abortion in Ewes editorial information www.nadis.org.uk 

H5N8 avian flu has been confirmed in a backyard flock of chickens and ducks near Thornton, Wyre, Lancashire.

A 3 km Protection Zone and a 10 km Surveillance Zone have been put in place around the infected premises to limit the risk of the disease spreading.

The infected flock contains nine birds. Defra says a number had died and the remaining live birds at the premises are being humanely culled. A full investigation is under way to determine the source of the infection.

Full details of the control measures in place can be found here.

ioLight, the world's first portable high resolution digital microscope, which premiered at the London Vet Show last year, has won a European Product Design Award 2017 and raised a further £320K in equity funding on the Crowdcube platform.

In 2014 ioLight co-founders, Oxford physicists Andrew Monk and Richard Williams, filed a patent application for a pocket-sized digital microscope with a performance that compares with expensive laboratory microscopes. They asked Cambridge Industrial Design to realise the product, briefing them that the device would need to deliver images with one micron resolution (required to view human or animal cells) onto a smartphone or tablet, be pocket-sized, easy to use, and economical to build in medium to high volumes.

One of the biggest challenges was in making the unit pocket-sized, which meant it had to be foldable, something which could have led to a loss in the rigidity needed to achieve high resolution images. This challenge was overcome with the use of a single hinge which the company says makes the ioLight both portable and robust.

Alex Jones, Managing director of Cambridge Industrial Design said: "We recognised immediately this was a great idea but the design brief was certainly a challenge. Fortunately, challenges can sometimes bring out the best in designers. The final design is a real success both aesthetically and ergonomically, and this award is a fantastic acknowledgement for the design process and the final product that we have created together with ioLight."

ioLight is also celebrating another success: closing its second round of equity funding after raising £320k from 335 investors on the Crowdcube platform (128% of the initial target). 

The company says the new funding will allow it to promote the microscope to a wide range of target markets including veterinary surgeons, education, laboratory and field research, museums and public engagement as well as to international markets. 

Andrew Monk, ioLight’s co-founder said: "The product is so simple to use that it is the ideal communication tool for explaining science to the public, students and customers. The microscope lets everyone see the same image so the discussion is about the picture not the tools. It’s a perfect fit for government public engagement campaigns, which are well funded at the moment. We are absolutely delighted that this funding provides us with the opportunity for both product development and to reach out and make microscopy available to so many more people."

The Royal College of Veterinary Surgeons has paid tribute to past President Lord Soulsby of Swaffham Prior, following news of his death on Monday, aged 90. 

Chris Tufnell, current President of the RCVS, said: "We are very sad to hear of the death of Lord Soulsby of Swaffham Prior, a figure who had a truly exceptional career, unique in its achievements and one dedicated to bridging and bringing together the worlds of medical and veterinary science.

"His dedication to the concept of One Health is demonstrated by the fact that, during his life time, he was both President of the Royal College of Veterinary Surgeons (from 1984-85) and the Royal Society of Medicine (1998-2000), the first veterinary surgeon to be elected to that position, as well as being a founding Fellow of the Academy of Medical Sciences.

"He was the recipient of numerous honorary degrees and prizes including Honorary Fellowship of the College and, at RCVS Day in 2015, received the Queen’s Medal, the highest award that the RCVS can bestow upon a veterinary surgeon. This was given in recognition of his contribution to One Health but also his international work as a Fellow and Professor in numerous countries across the world and his political work as the first veterinary surgeon to enter the House of Lords in 1990.

"He gave an outstanding service to the profession, to veterinary science and to animal welfare but was known for his endearing personality as much as his intellect. He will be missed by many colleagues in the veterinary world but his legacy will live on through inspiring veterinary surgeons from all walks of life to work more closely with other healthcare and medical professionals and through his numerous published books and papers. Our sympathies are with his family and friends."

Photo: Lord Soulsby getting a standing ovation at RCVS Day 2015. Courtesy RCVS. 

The British Veterinary Association has responded to the Scottish Government's latest animal welfare measures, which include a ban on wild animals in travelling circuses and legislation to permit tail shortening for spaniels and hunt point retrievers intended for use as working dogs.

BVA Scottish Branch President Grace Webster said: "We commend the Scottish Government on seizing the opportunity to improve animal welfare through the introduction of a Bill to ban of the use of wild animals in travelling circuses. While the use of wild animals in travelling circuses may not affect a great number of individual animals, it is emblematic of the way we treat all animals and we would urge the rest of the UK to follow this precedent, introduced on ethical grounds.

"However, this package of measures seems a bit of a mixed bag. Until recently Scotland also led the way on dog welfare with a complete ban on tail docking, so we are extremely disappointed at the decision to reverse this stance. We have carefully considered all the evidence and remain convinced that tail docking in dogs, even specific breeds, is detrimental to their welfare. This is a retrograde step for animal welfare in Scotland, amidst an otherwise progressive package of animal welfare measures."

At the end of May, BVA Scottish Branch Junior Vice President Melissa Donald will be giving evidence to the Environment Committee in the Scottish Parliament ahead of a vote on whether or not to approve the change in law relating to tail docking.

Today’s announcement by the Cabinet Secretary for Environment, Climate Change and Land Reform Roseanna Cunningham MSP also included the introduction of controls to restrict the use of electronic training collars and a commitment to update regulations to combat the irresponsible breeding and sale of dogs, cats and rabbits.

Gudrun Ravetz, BVA President, added: "Animal welfare starts right at the beginning of a pet’s life, so the focus on pet licensing and breeding regulations is welcome. We know that a third of vets are seeing puppies they believe to have been illegally imported and an increasing number of owners are buying brachycephalic or designer breeds, like Scottish fold cats; pets must be purchased with owners prioritising animal health and welfare, rather than making an impulse buy based on looks alone.

"Yet we are saddened at the shortfall on legislation around aversive training aids for dogs, which we expect will still permit the use of training collars under expert guidance. We know using fear as a training tool is not only less effective than positive reinforcement, but can take its toll on a dog’s overall welfare. Without an outright ban, we have grave concerns over how enforceability will work. This raft of measures seems to give with one hand and take away with the other."

Zoetis has produced new guidance to help veterinary surgeons develop successful strategies for controlling worms in foals and youngstock.

According to the company, information on best worming strategies for foals and yearlings remains largely anecdotal, making it difficult to develop a clear plan for this age group. Zoetis veterinary surgeon Wendy Talbot has therefore reviewed the recent literature to develop an eight-point plan. 

Explaining the guidance, Wendy writes:

Foals and yearlings are usually more susceptible to worms than are adult horses because they have had little chance to develop any immunity. They are more vulnerable to related diseases and tend to have higher egg shedding, which increases the risk of infection. The main parasitic culprits in the UK for foals less than six months of age are large roundworms (ascarids). In older foals and weanlings, small and large strongyles, tapeworms (and pinworms) are the main considerations.¹ Yearlings may also have a second wave of large roundworm infection at 8-10 months of age.² Any control strategy will need to take into account the individual circumstances such as stocking density, pasture management and previous disease history.

Guidelines for parasite control in foals suggest a first treatment with fenbendazole at 2-3 months of age, targeting large roundworm, followed by another treatment at 5-6 months. Alternatively, pyrantel may be considered for these doses; however, there may be resistance in some areas and foals with large adult ascarid burdens may be at higher risk of intestinal rupture when this drug is used.⁴ At weaning (approximately six months of age), it is advisable to perform a faecal worm egg count (FWEC) to determine if treatment for strongyles is also required; the macrocyclic lactone anthelmintics (ivermectin or moxidectin) are expected to have the highest efficacy. At 9 and 12 months of age treatment for stronglyes and a larvicidal dose for encysted stages of small strongyles (moxidectin or a 5 day course of fenbendazole) are indicated.  A tapeworm treatment should be included with one of these doses.^2,3

For yearlings, two methods have recently been proposed for worm control: the first involves using faecal worm egg counts (FWECs) at more frequent intervals than for adults to guide dosing for strongyles in the grazing season.¹ The second suggests three baseline treatments targeting strongyles in spring, summer and late autumn, with FWECs in between to identify and treat any still shedding high numbers of eggs, up to a maximum of six treatments per year.² Macrocyclic lactones have the highest expected efficacy against small strongyles and should form the basis of treatments; however, pyrantel can be considered for some treatments where it has been shown to have continued efficacy. Both strategies include a larvcidal treatment for encysted small redworm combined with testing or treating for tapeworm in late autumn. The inclusion of one or two doses of a macrocyclic lactone each year (usually already used for small strongyle control) should be sufficient to prevent large strongyle related disease.³

The wide differences in the circumstances of foals and yearlings, together with geographical variations in resistance patterns and a lack of consensus on best practice in this group means it is not possible to define a single approach to a worming plan. An important point to note is that FWECs may give surprising results because higher counts are generally seen in youngstock.

Eight ways to keep clients' youngstock worms controlled:

1. Clean pasture is key to keeping foals and youngstock healthy. Regular removal of droppings is crucial to a successful worm control plan.
2. All foals are considered to be susceptible and at risk of acquiring ascarid infection. Some degree of anthelmintic intervention should be considered and in most circumstances administration at 2-3 months of age and again at 5-6 months of age is advisable.⁴
3. Older foals are primarily at risk of strongyle infection; macrocyclic lactone anthelmintics have the highest expected efficacy.
4. Worm egg counts are likely to be higher in yearlings compared to adults and interpretation of them requires good knowledge of all the circumstances including management, clinical history, previous worm control and test results. Cut-off values for treatment have been suggested to be between 100-500 epg.
5. Moxidectin for the treatment of encysted small redworm is advised for all youngsters (> 6 months of age) in late autumn.¹
6. Faecal worm egg counts are advisable in late winter/start of spring to identify high shedders. These should be treated as necessary with moxidectin particularly after a mild winter.¹
7. New arrivals should be dosed with moxidectin and then quarantined for three days.¹
8. A yearly faecal egg count reduction test is advised to check efficacy against strongyles and ascarids for all class of drugs used on the premises.¹

For further information on worming together with some equine specific CPD visit: https://blog.vetsupportplus.com/

1. Matthews www.vettimes.co.uk/article/helminth-control-programmes-for-equine-yearlings-at-pasture/
2. Nielsen (2017) Endoparasite Control. 9^th ECEIM congress proceedings, 63-64
3. AAEP (2016) Parasite Control Guidelines
4. Nielsen (2016) Evidence-based considerations for control of Parascaris spp. infections in horses. Equine vet. Educ.  28 (4) 224-231

The Equine Veterinary Journal has published a free special collection of new research on Equine Grass Sickness this month.

Four separate studies are included in the collection, reporting novel risk factors for the disease, identifying key differences between EGS and botulism (questioning the hypothesis that EGS is caused by neurotoxins from Clostridium botulinum), reporting a novel diagnostic technique and showing the value of monitoring weight loss to help predict whether individual horses with chronic EGS are likely to survive.

The publishers say that despite more than 100 years of research, supported predominantly by the The Moredun Foundation Equine Grass Sickness Fund (www.grasssickness.org.uk), the cause of EGS remains unknown. Since it almost exclusively affects grazing horses, a pasture derived neurotoxin is implicated. EGS causes gut paralysis as a result of damage to parts of the nervous system that control involuntary functions. Acute and sub-acute EGS is invariably fatal while around 55% of chronic cases can survive and return to a useful working life. The UK has the highest incidence of EGS in the world; indeed it is estimated that the disease kills between 1 and 2% of horses in the United Kingdom annually. Cases are more common in spring.

In terms of risk factors, the study ‘Equine grass sickness in Scotland: A case-control study of environmental geochemical risk factors’ suggests that the high incidence of the disease in Eastern Scotland may be partly associated with the particular composition of macro and trace elements in the soil in the fields on which horses graze. Further work is required to determine whether interventions to alter concentrations of particular elements in soil could potentially reduce the risk of EGS.¹

A second study identified key differences between EGS and botulism, which questions the currently favoured hypothesis that EGS is caused by neurotoxins from Clostridium botulinum, a bacterium which commonly inhabits soil. The study ‘Equine grass sickness, but not botulism, causes autonomic and enteric neurodegeneration and increases soluble N-ethylmaleimide-sensitive factor attachment receptor protein expression within neuronal perikarya’ suggests that EGS is unlikely to be caused by neurotoxins from this bacterium and concludes that further investigation of an alternative cause for EGS is needed.²

While the majority of horses with EGS can be readily diagnosed by experienced veterinary surgeons, some cases present a diagnostic challenge. Indeed the only way to definitively diagnose the disease in a live horse is to demonstrate the characteristic degeneration of nerves within biopsies of the intestine. Unfortunately these biopsies can only be collected by performing abdominal surgery under general anaesthesia. In the study ‘Neuronal chromatolysis in the subgemmal plexus of gustatory papillae in horses with grass sickness’ characteristic degeneration of nerves was identified in small biopsies collected from tongues of EGS horses during post mortem examination. Examination of these biopsies accurately differentiated control horses from EGS cases. While further validation of this technique is required, it could potentially provide a relatively non-invasive method of confirming the diagnosis in a live horse.³

While around 55% of horses with chronic EGS survive, objective criteria for predicting survival of these cases are currently lacking. The study ‘Bodyweight change aids prediction of survival in chronic equine grass sickness’ reported that non-survivors had greater rate and magnitude of bodyweight loss than survivors. Survival prediction curves were published to allow veterinary surgeons and horse owners to use body weight data to help determine whether an individual horse with chronic EGS was likely to survive or die.⁴

Professor Bruce McGorum, Head of the Equine Section at the Royal (Dick) School of Veterinary Studies & Roslin Institute in Edinburgh, has been leading much of the research. He said: "Given that our recent research suggests that EGS is unlikely to be caused by neurotoxins from Clostridium botulinum we are now moving on to determine whether EGS is caused by ingestion of mycotoxins produced by pasture fungi. We are very pleased that The Horse Trust (www.horsetrust.org.uk) has provided funding for this three-year investigation."

Professor Celia Marr, Editor of the Equine Veterinary Journal said: “While the cause of equine grass sickness continues to evade us, these papers present an optimistic step in the right direction for the eventual prevention of this dreadful disease. It is only with the support of the Moredun Foundation Equine Grass Sickness Fund and more recently that of The Horse Trust that our world-leading veterinary researchers are able to continue to unravel the mystery.”

The EVJ equine grass sickness collection can be downloaded at http://bit.ly/2dC7Drr

References

1. Equine grass sickness in Scotland: A case-control study of environmental geochemical risk factors C. E. Wylie, D. J. Shaw, F. M. Fordyce, A. Lilly, R. S. Pirie, B. C. McGorum
2. Equine grass sickness, but not botulism, causes autonomic and enteric neurodegeneration and increases soluble N-ethylmaleimide-sensitive factor attachment receptor protein expression within neuronal perikarya B. C. McGorum, S. Scholes, E. M. Milne, S. L. Eaton, T. M. Wishart, R. Poxton, S. Moss, U. Wernery, T. Davey, J. B. Harris, R. S. Pirie
3. Neuronal chromatolysis in the subgemmal plexus of gustatory papillae in horses with grass sickness B. C. McGorum, R. S. Pirie, D. Shaw, N. Macintyre, A. Cox
4. Bodyweight change aids prediction of survival in chronic equine grass sickness R. C. Jago, I. Handel, C. N. Hahn, R. S. Pirie, J. A. Keen, B. E. Waggett, B. C. McGorum

The number of veterinary students suffering from stress has dropped by 23% over the last four years, according to a survey conducted by the British Veterinary Association (BVA) and the Association of Veterinary Students (AVS).

In the BVA/AVS Survey 2012, sponsored by Vets4Pets, 82% of students reported suffering from stress currently or while at university, with this figure falling to 63% of students in 2016. Those who reported suffering from depression also fell from 33% to 27%.

By far the biggest contributor to, or trigger of, mental health problems was veterinary students’ studies, with 83% citing this as the main reason. Other contributions to, or triggers of, mental health issues cited by students included:

• Lack of free time (58%)
• Relationship or family issues (44%)
• Other financial worries (40%)
• Stress of finding extra-mural studies (EMS) placements (34%)
• The cost of EMS (23%)
• Having to work as well as study (19%)
• Other (9%)

Researchers say that the fall in students reporting stress could be attributed to improved university support for students, with almost three quarters (72%) of survey respondents saying they felt supported in terms of welfare.

In recent years, a number of initiatives have been developed to help and support students. They range from the counselling and peer mentoring services available through individual universities to the confidential support offered by the independent charity Vetlife through its helpline, health support programme and fund for financial support.

While the significant fall in veterinary students reporting stress is positive, the BVA/AVS survey also shows that there are a range of factors that affect students, including financial pressures. A third of veterinary students work part-time to supplement their income and around half of students say they usually have less funds than they need, with the average shortfall per term estimated at £1,231.

Hannah Mason, President of the Association of Veterinary Students, said: "There is no escaping that veterinary medicine is a challenging degree. On top of strenuous exams, holidays are filled with compulsory EMS making it hard to sustain part-time work which is often needed to supplement the expense of a five or six year degree. It is therefore no surprise that stress is a problem in the vet student population. Whilst it is pleasing to see that the numbers reporting stress have declined, the majority of vet students still report having suffered at some point during their degree. We now have various counselling services and peer support systems across the universities to help students to cope better. However, while it is important to have reactive strategies in place, we also need to examine the fundamental reasons why vet students are stressed and how we can prevent it from occurring."

Gudrun Ravetz, President of the British Veterinary Association, said: "A significant drop in those students reporting stress is very much to be welcomed. But any veterinary student feeling stressed, under pressure and unable to cope is one too many. The truth is that there will be pressure in the work we do and there will be times that we feel stressed. Veterinary medicine university courses are tough and that is reflected in studies being the number one contributor to mental health and wellbeing concerns in the survey. But as a veterinary family, we need to help our colleagues to cope from the earliest stages of their career and make the right resources available to them, along with creating the right kind of supportive culture. We also need to recognise and work on solutions for what can be a toxic mixture of a highly demanding course, little leisure time and huge financial pressure. It is the responsibility of everyone in the profession to nurture a robust, skilled, compassionate and happy new generation of vets."

The Dachshund Breed Council, with support from CVS Group, is launching a UK screening programme for Intervertebral Disc Disease (IVDD).

The organisation says back disease is by far the most common health problem in UK Dachshunds: around 1 in 4 may be affected at some stage in their lives. Whilst many recover well in time, there is significant risk of permanent damage so severe that it is life-changing or life-threatening. 

Research in Scandinavia has shown that there is a good correlation between calcification of the discs and clinical disc herniations when dogs are X-ray screened between the ages of two and four. The Breed Council has based the screening programme on the Scandinavian protocols and CVS has offered to screen the dogs cost-effectively at a number of its clinics across the UK. The company will also be collaborating on a multi-year research study of the dogs participating in the scheme to monitor its success.

Ian Seath, Chairman of the Breed Council, said: "X-ray screening has been used in Scandinavia for several years and is currently the best available tool to help us reduce the genetic risk of IVDD. All six varieties of Dachshund in the UK are encouraged to participate. The aim of X-ray screening is to reduce the occurrence of herniations by encouraging breeding with dogs that have low numbers of calcifications."

Specialist neurologist, Dr Mark Lowrie from the CVS-owned Dovecote Veterinary Hospital in Castle Donnington, said: "We feel it is important that breeders, owners and vets work together to try and reduce the prevalence of this condition which can cause catastrophic changes to a dog’s quality of life and much upset for dedicated and caring owners."

Dachshund owners can find out more about the scheme at a newly developed website www.dachshund-ivdd.uk. The website is also a source of advice and guidance for Dachshund owners who want to learn more about IVDD and the options available if their dog should suffer a back problem.

ioLight, the first professional-quality pocket microscope which launched back in May (discussed here), will be presented to the profession at the Bayer stand (R20) at the London Vet Show, where it will be used to demonstrate Bayer's products.

The founders of ioLight, Andrew Monk and Richard Williams, will be in attendance on the Bayer stand to answer questions about the new product.

James Crawford, Head of Marketing at Bayer, said: "Bayer is delighted to present the ioLight microscope on our stand at the London Vet Show 2016. The microscope provides fantastically clear images and is simple to use, showing off Bayer's products for all our customers to see."

Professor Mike Taylor, a Diplomate of the European Veterinary Parasitology College, is in the process of evaluating the ioLight microscope as a tool for the diagnosis of parasitic infections of farm animals.

Normally he uses a laboratory microscope for this work but they are not routinely used on a farm. He has also tried a portable digital microscope, but finds it does not give the resolution required for identification of protozoan parasite species or for counting nematode eggs. Mike said: "The ioLight’s portability, image quality and connectivity to the Apple iPad offer great potential for the development of rapid methods for identifying parasites, or determining parasite burdens. I can envisage its use by both veterinarians and suitably trained livestock farmers, in the practice laboratory or directly on the farm."

Andrew Monk said: "Since our launch earlier this year we have seen a massive interest from the veterinary sector. We are thrilled to have the opportunity to demonstrate our microscope to such a large audience, and are looking forward to working with Bayer."

For more information visit iolight.co.uk or email Andrew Monk at andrew.monk@iolight.co.uk.

White Cross Vets has announced the launch of a new practice designed to offer patients, clients and staff the best possible environment, whilst at the same time being environmentally-friendly.

Located in Wolverhampton, the new practice uses different lighting in different parts of the building: 'cool' for public areas such as the waiting room, 'comfortable warm' for the dog, cat and exotic wards and daylight for clinical areas. The LED system uses 60% less energy than conventional lighting and requires half the number of fittings. In addition, following research in the USA at Banfield, consulting rooms are fitted with dimmable lights to ease stress for patients and clients during euthanasia.

Other highlights include a specialist cat ward that White Cross says exceeds the iCatCare Cat Friendly Clinic requirements. The ward includes raised cat kennels that are carefully positioned so that cats can’t see each other, to further minimise stress-levels. There are also separate, sound-proofed wards for dogs and exotic pets.

To reduce anxiety in dogs and cats pre- and post-surgery, the practice uses pheromone diffusers and specially composed music played in the wards.

Managing Director, Tim Harrison said: "We’re delighted to launch our latest practice in Wolverhampton, which is our most environmentally-friendly yet. We’ve incorporated the most successful attributes from all of our 15 other UK practices into its design, and it’s immediately proving popular with clients and most importantly their pets."

Clinic Director James Millington says: "The facilities and attention to detail in this practice are the best I’ve ever seen. There’s no doubt this will translate into the quality of care that our clients receive and their pets deserve."

MSD Animal Health has announced the launch of 'Be Active', a new campaign to support veterinary practices and encourage more clients to bring in their older cats for a six-month health screening.   

The company says that the campaign has been launched in response to a survey it conducted amongst pet owners which found that more than half had never consulted their vet about their aging pets. 58% admitted that they were unaware of the signs of aging in their pets, and 45% said they were unaware that something could be done to help pets as they get older¹.

Karland King, Brand Manager for Established Brands at MSD Animal Health said: "Our Pet Owner Survey reveals missed opportunities for vets to educate their clients, and cat owners to ensure they get the best advice and preventative care for their older cats.

"Our new Be Active campaign has therefore been designed to support vets in this education process and supply a pack of resources for them to actively encourage clients to seek advice and regular checks from their vet. It aims to help vets position themselves as the best source of information and support for clients with older cats, helping older cats stay healthier and more active for longer, starting with a six-monthly health check."

The World Small Animal Veterinary Association recommends that most pets have an annual health check². As cats get older or start receiving treatment for long-term conditions such as diabetes or hyperthyroidism, it is recommended that the veterinary examination is increased to every six months³.  

To support the Be Active campaign MSD Animal Health has produced a range of resources for veterinary practices, including promotional leaflets and posters, and a PR toolkit with advice and materials to help veterinary surgeons promote their practices and support the campaign locally. 

For further information, contact your MSD Animal Health representative.

References

1. MSD Animal Health Pet Owners Survey 2016 – Pet Owner Market Research conducted by Dr Emmanuel Streel, Consultant  http://www.wsava.org/default/files/WSAVA%20vaccination%20Guidelines%202015%20Full%29Version.pdf (accessed Sept 2016)
2. WSAVA Vaccination Guidelines Group, Guidelines for the vaccination of dogs and cats (Jan 2016).
3. AAFP Senior Care Guidelines. J Feline Med Surg 2009;11(9):763-78.